NANTES, France & TOKYO–(BUSINESS WIRE)–Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based products, and the Tokyo Metropolitan Institute of Medical Science (TMIMS), today announce their collaboration for the development of a new mpox vaccine using a live-attenuated vaccine. Mpox is a viral illness caused by the monkeypox virus. It … [Read more…]

Collaboration will leverage AGC Biologics’ commercial manufacturing experience and proven platforms to seek regulatory approval for a therapy treating the rare immunodeficiency disorder, ADA-SCID. MILAN–(BUSINESS WIRE)–#Biotech–AGC Biologics, your friendly CDMO expert, today announced an agreement with Rarity PBC to provide comprehensive development and Good Manufacturing Practice (GMP) manufacturing for Rarity’s gene therapy, RDP-101, for Adenosine … [Read more…]

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commercial and innovation momentum across its portfolio. Record net sales of 3.737 billion USD for the first … [Read more…]

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Scienza Health, a pioneer in AI-powered healthcare, and Samsung announce a collaboration delivering advanced patient screening, engagement, and monitoring through Galaxy smartwatches, phones, and tablets. Scienza’s digitalhumanOS™ and ERaaS™ platform uses ambient speech analysis and real-time biometric data to support cognitive and neurological health screenings, automate clinical workflows, and improve patient and … [Read more…]

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will present at the 7th Annual Wolfe Research Healthcare Conference on Monday, November 17th, 2025. Management will participate in a Fireside Chat at 10:40 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “AI in Biotechnology: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 … [Read more…]

WATERLOO, Iowa–(BUSINESS WIRE)–HOMELINK®, a leading provider of integrated specialty services for the workers’ compensation and group health industries, is pleased to welcome Allan Schroeder, J.D., as vice president of managed care. Schroeder is a seasoned executive with a deep background in clinical review services and healthcare operations. “Allan brings a great combination of strategic insight … [Read more…]

RC Capital, Mutual Capital Partners and Western Alliance Bank reinforce long-term confidence in Catalyst’s vision and leadership; Dr. Theodore Blaine joins Catalyst board of directors NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced the close of $15 million in equity and debt financing, … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biosciences—Mispro today announced the opening of its newest contract vivarium facility in Kendall Square, Cambridge, scheduled to open in December 2025. Located in the heart of the world’s leading life sciences hub, the new facility will be Mispro’s ninth in the Greater Boston area and third in Kendall Square, strengthening its position as … [Read more…]

The PROCLIPI study, one of the largest studies to date in cutaneous T-cell lymphoma (CTCL), is a prospective, observational, multicentre international registry spanning 19 countries and includes over 2,000 patients, collects data to develop prognostic indices for CTCL1 An analysis of 371 patients observed meaningful overall survival (OS) benefit for patients with advanced mycosis fungoides … [Read more…]